DRONEDARONE

SynDRA canonical compound SYN0005656 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	ADRA1A \| ADRA1B \| ADRA1D \| ADRA2A \| ADRA2B \| ADRA2C \| ADRB1 \| CACNA1C \| CACNA1D \| CACNA1F \| CACNA1S \| CACNB1 \| CACNB2 \| CACNB3 \| CACNB4 \| KCNA5 \| KCNH2 \| KCNK2 \| SCN1A \| SLC22A2 \| SLC22A8 \| SLCO1B3
Mechanism of action	adrenergic receptor antagonist
Indication	atrial fibrillation (AF)
Disease area	cardiology

All known targets

multaq
dronedarone hydrochloride
SR33598B
dronedarone HCl
Dronedarona
SR-33589
SR33589
Multaq
Dronedarone [INN]
SR 33589
SR 33589B
Dronedarone (INN)
Sanofi-Aventis brand of dronedarone
N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-1-benzofuran-5-yl]methanesulfonamide
N-(2-Butyl-3-(p-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide
N-[2-butyl-3-{4-[3-(dibutylamino)propoxy]benzoyl}-1-benzofuran-5-yl]methanesulfonamide
N-(2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide
DRONEDARONE BASE
CHEMBL184412
JQZ1L091Y2
CHEBI:50659
Methanesulfonamide, N-(2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-
NCGC00188863-01
Methanesulfonamide, N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-5-benzofuranyl]-
N-(2-butyl-3-{4-[3-(dibutylamino)propoxy]benzoyl}-1-benzofuran-5-yl)methanesulfonamide
UNII-JQZ1L091Y2
CAS-141626-36-0
Dronedarone [INN:BAN]
HSDB 7928
DRONEDARONE [MI]
DRONEDARONE [VANDF]
DRONEDARONE [MART.]
DRONEDARONE [WHO-DD]
SCHEMBL110363
DRONEDARONE [EMA EPAR]
GTPL7465
DTXSID3048653
HMS3749G19